Petri Bono
- Oncology top 0.5%
- Molecular Biology top 2%
- Pulmonary and Respiratory Medicine top 0.5%
- Cancer Research top 1%
- Immunology top 2%
- Co-authors
- Heikki JoensuuSirpa JalkanenVesa KatajaKari AlitaloMarko SalmiPipsa SaharinenLauri EklundStefan Michiels
- Topics
- Renal cell carcinoma treatment (35 papers)Cancer Immunotherapy and Biomarkers (28 papers)HER2/EGFR in Cancer Research (21 papers)
- Journals
- Journal of Clinical InvestigationThe Journal of Experimental MedicineJournal of Clinical Oncology
- Partner nations
- FinlandUnited StatesUnited Kingdom
In The Last Decade
Petri Bono
153 papers receiving 7.4k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Oncology 3.9k
- Molecular Biology 2.7k
- Pulmonary and Respiratory Medicine 2.4k
- Cancer Research 1.6k
- Immunology 1.3k
Countries citing papers authored by Petri Bono
This map shows the geographic impact of Petri Bono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petri Bono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petri Bono more than expected).
Fields of papers citing papers by Petri Bono
This network shows the impact of papers produced by Petri Bono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petri Bono. The network helps show where Petri Bono may publish in the future.
Co-authorship network of co-authors of Petri Bono
This figure shows the co-authorship network connecting the top 25 collaborators of Petri Bono. A scholar is included among the top collaborators of Petri Bono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petri Bono. Petri Bono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 60 | |
| 4 | 9 | |
| 5 | 41 | |
| 6 | 1 | |
| 7 | 9 | |
| 8 | 1 | |
| 9 | 178 | |
| 10 | 95 | |
| 11 | 5 | |
| 12 | 20 | |
| 13 | 9 | |
| 14 | 149 | |
| 15 | 112 | |
| 16 | 22 | |
| 17 | 27 | |
| 18 | 20 | |
| 19 | 26 | |
| 20 | 55 |
About Petri Bono
Petri Bono is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 156 papers that have together received 7.5k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (35 papers), Cancer Immunotherapy and Biomarkers (28 papers) and HER2/EGFR in Cancer Research (21 papers). The work is most often cited by research in Oncology (3.9k citations), Cancer Research (1.6k citations) and Gastroenterology (432 citations). Petri Bono has collaborated with scholars based in Finland, United States and United Kingdom. Frequent co-authors include Heikki Joensuu, Sirpa Jalkanen, Vesa Kataja, Kari Alitalo, Marko Salmi, Pipsa Saharinen, Lauri Eklund, Stefan Michiels, Sherene Loi and Debora Fumagalli. Their work appears in journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.